We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$321M
AUM Growth
-$65.2M
Cap. Flow
-$14.2M
Cap. Flow %
-4.41%
Top 10 Hldgs %
46.24%
Holding
97
New
Increased
17
Reduced
43
Closed
15

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$5.45M
2
ZM icon
Zoom
ZM
+$4.82M
3
PYPL icon
PayPal
PYPL
+$3.72M
4
META icon
Meta Platforms (Facebook)
META
+$3.35M
5
GLW icon
Corning
GLW
+$598K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$6.69M
2
NTR icon
Nutrien
NTR
+$3.7M
3
T icon
AT&T
T
+$3.5M
4
MOS icon
The Mosaic Company
MOS
+$3.32M
5
BG icon
Bunge Global
BG
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 17.48%
2 Consumer Staples 17.04%
3 Materials 12.89%
4 Communication Services 10.33%
5 Technology 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$131B
$35.9M 11.18%
213,210
-7,560
-3% -$1.32M
ALB icon
2
Albemarle
ALB
$13.9B
$16.7M 5.2%
79,829
-1,247
-2% -$278K
KHC icon
3
Kraft Heinz
KHC
$30.7B
$14.9M 4.63%
390,210
-15,960
-4% -$639K
FDX icon
4
FedEx
FDX
$72.7B
$14.4M 4.48%
63,099
-2,616
-4% -$558K
BG icon
5
Bunge Global
BG
$20.4B
$12.5M 3.9%
138,143
-19,328
-12% -$2.14M
NTR icon
6
Nutrien
NTR
$33.2B
$11.8M 3.67%
147,446
-38,104
-21% -$3.7M
MRK icon
7
Merck
MRK
$322B
$11.4M 3.54%
123,792
+1,402
+1% +$124K
IONS icon
8
Ionis Pharmaceuticals
IONS
$8.6B
$10.7M 3.33%
288,751
-16,031
-5% -$605K
GILD icon
9
Gilead Sciences
GILD
$162B
$10.5M 3.27%
169,900
-785
-0.5% -$48.6K
SYY icon
10
Sysco
SYY
$40.8B
$9.8M 3.05%
115,065
-18,025
-14% -$1.51M
INTC icon
11
Intel
INTC
$455B
$8.76M 2.73%
234,126
-35,069
-13% -$1.52M
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.36T
$8.65M 2.69%
79,360
+2,480
+3% +$292K
PYPL icon
13
PayPal
PYPL
$48.9B
$8.6M 2.68%
123,199
+42,839
+53% +$3.72M
ZM icon
14
Zoom
ZM
$28.2B
$8.53M 2.65%
78,959
+45,751
+138% +$4.82M
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
$8.11M 2.53%
214,051
-7,940
-4% -$341K
T icon
16
AT&T
T
$159B
$8.08M 2.51%
385,413
-175,689
-31% -$3.5M
KO icon
17
Coca-Cola
KO
$377B
$7.59M 2.36%
119,869
-10,630
-8% -$674K
MOS icon
18
The Mosaic Company
MOS
$7.03B
$7.05M 2.2%
149,350
-54,150
-27% -$3.32M
SLB icon
19
SLB Ltd
SLB
$73.6B
$6.94M 2.16%
192,861
-19,500
-9% -$813K
WFC icon
20
Wells Fargo
WFC
$261B
$6.66M 2.07%
169,962
+3,795
+2% +$167K
NFLX icon
21
Netflix
NFLX
$299B
$6.59M 2.05%
376,850
+245,800
+188% +$5.45M
META icon
22
Meta Platforms (Facebook)
META
$1.42T
$6.06M 1.89%
37,608
+17,371
+86% +$3.35M
CPB icon
23
Campbell Soup
CPB
$6.55B
$5.62M 1.75%
116,880
+500
+0.4% +$23.6K
GH icon
24
Guardant Health
GH
$21.5B
$5.56M 1.73%
137,889
+4,223
+3% +$209K
AAPL icon
25
Apple
AAPL
$4.54T
$5.05M 1.57%
36,943
-14
-0% -$2.12K

Similar funds

Sicart Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Sicart Associates held 97 positions worth $321M, down 17% from $386M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sicart Associates withdrew a net $14.2M in Q2 2022, closing 15 positions and reducing 43 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $6.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Materials.

Against the trend, Sicart Associates added an estimated $5.45M to Netflix.

  • Sicart Associates added most to Netflix in Q2 2022, an estimated $5.45M increase.
  • Sicart Associates's biggest Q2 2022 reduction was Nutrien, cutting an estimated $3.7M.
  • Sicart Associates fully exited Pioneer Natural Resource Co. in Q2 2022, selling an estimated $6.69M.
  • Sicart Associates's ten largest holdings make up 46% of its $321M portfolio in Q2 2022.
  • Sicart Associates opened 0 new positions and closed 15 in Q2 2022.
  • Sicart Associates's portfolio value fell 17% quarter-over-quarter to $321M.

Based on Sicart Associates's 13F filing for Q2 2022, filed 5 Aug 2022.